Clinical Trials List
Protocol NumberLBS-008-CT05
Active
2023-04-22 - 2026-10-30
Phase III
ICD-10H35.30
Unspecified macular degeneration
ICD-9362.50
Macular degeneration (senile), unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- 李昱逵 Division of Ophthalmology
- Yi-Sheng Chang Division of Ophthalmology
Principal Investigator
Co-Principal Investigator
- 謝易庭 Division of Ophthalmology
- TZYY-CHANG HO Division of Ophthalmology
- TSO-TING LAI Division of Ophthalmology
- CHUNG-MAY YANG Division of Ophthalmology
Principal Investigator
Co-Principal Investigator
- 陳冠任 Division of Ophthalmology
- Chi-Chun Lai Division of Ophthalmology
- 趙安年 Division of Ophthalmology
- 陳怡杏 Division of Ophthalmology
- 劉珍吟 Division of Ophthalmology
- Wei-Chi WU Division of Ophthalmology
Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
500 participants
